Clipping of news on Brazilian Culture, Law and Citizenship
30/10/2012
This article was translated by an automatic translation system, and was therefore not reviewed by people.
The National Agency for Sanitary Surveillance (ANVISA) published in the Official Gazette (DOU) on Thursday (25/10), the company's voluntary recall Bristrol Myers Squibb Pharmaceuticals. The company announced the withdrawal of some batches of the product Becenum for detecting unsatisfactory results in the presentation of liófilo powder for injectable solution and identify content Carmustine specified below.
Please batches collected:
Lot 0J63041, manufactured in May 2010 with expiration date in May 2013; 0L61449, manufactured in September 2010 with expiration date September 2013; 1C00811, fabicado in January 2013; 1C00811, manufactured in January 2011 with January 2014 expiry date; 1G00501 , manufactured in April 2011 with expiration date in March 2014, and 1J00051, manufactured in April 2011 with April 2014 expiration date.
other products
The Laboratory of Boehringer Ingelheim Brazil will also make the voluntary recall of lot 107 560 (manufactured in 10/2011 and with validity 10/2014) aerosol product Berotec 100mg/dose 10 ml. The plot, intended only for distribution of free samples, was mixed with the original product and sent to distributors in internal control failure of the expedition.
The company Gezyme Do Brazil Ltda also announced the voluntary recall of the batch C0072 product Thymoglobuline Liófilo 25 mg powder for injectable solution. The collection is necessary due to deviation in quality compared to the profile of polymers / aggregates and fragments (PAF).
Source: ANVISA
Our news are removed entirely from the sites of our partners. For this reason, we can not change their content even in cases of typos.
This article was translated by an automatic translation system, and was therefore not reviewed by people.